By: Kairos Ventures On: June 2, 2022 In: 3D Bio, Portfolio News

3DBio Therapeutics, a biotech company in Queens, said it had for the first time used 3-D printing to make...

Read more
By: Kairos Ventures On: June 2, 2022 In: 3D Bio, Portfolio News

3DBio and the Microtia-Congenital Ear Deformity Institute announced they have conducted a human ear reconstruction using the AuriNovo™ implant,...

Read more
By: Kairos Ventures On: December 6, 2019 In: 3D Bio, Portfolio News

3D Bio announced that the FDA has granted Rare Pediatric Disease designation for AuriNovo™, an investigational combination product for...

Read more
By: Kairos Ventures On: November 19, 2019 In: 3D Bio, Portfolio News

3D Bio has received Orphan Drug Designation for AuriNovo™, an investigational combination product for reconstruction of the outer ear...

Read more
By: Kairos Ventures On: April 2, 2019 In: 3D Bio, Portfolio News

3D Bio announced the appointment of Sol Barer, Ph.D. and Kevin Slawin, M.D. to its Board of Directors.  Dr....

Read more
By: Kairos Ventures On: July 19, 2017 In: 3D Bio, Kairos II, Portfolio News

We are excited to announce that Kairos Venture Partners II, L.P., our second fund, has made its first investment...

Read more